Online ISSN: 2331-4737



Groundbreaking Research Reveals New Target for Leukemia Treatment

December 7, 2017
Interrupting the communication between cells is a method of treating cancer. Recent research has identified two cell signaling processes that could be a new target for leukemia treatment. In a 2016 issue of Nature, researchers identified two specific factors that “read” the information in DNA—and use it to create the traits we can observe. These specific transcription factors are important to cell signaling in chronic myeloid leukemia, a rare blood cancer that begins in bone marrow. Disrupting that reading process may allow scientists to target and kill cancer cells. Professor Tessa Holyoake and colleagues from the Paul O’Gorman Leukaemia Research… continue reading »